Erythromycin Estolate

CHEMBL2218877 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

1056.4 g/mol

LogP

—

Phase

4

The estolate ester form of erythromycin, this antibiotic is absorbed more readily from the gastrointestinal tract and converted to active erythromycin in the body. It is used to treat bacterial infections in patients who need an oral form.

Peso molecular

1056,4000 g/mol

TPSA

272,00 Å²

Áreas terapéuticas

Artritis reumatoide Asma Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Diabetes tipo 2 Dolor crónico Enfermedad cardiovascular Enfermedad del hígado graso no alcohólico Enfermedad de Parkinson Enfermedad infecciosa Enfermedad por reflujo gastroesofágico Enfermedad pulmonar obstructiva crónica Enfermedad renal crónica Esclerosis múltiple Fibrilación auricular Glaucoma Hepatitis C Hipertensión Ictus Insomnio Insuficiencia cardíaca Leucemia Linfoma Malaria Manejo del dolor Melanoma Obesidad Trastorno de ansiedad generalizada Trombosis venosa profunda / Embolia pulmonar Tuberculosis VIH/sida

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O

InChI

InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1

Molecular Formula

C52H97NO18S

HBD / HBA

5 / 19

Enlaces Rotables

22

Átomos Pesados

72

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

The estolate ester form of erythromycin, this antibiotic is absorbed more readily from the gastrointestinal tract and converted to active erythromycin in the body. It is used to treat bacterial infections in patients who need an oral form.

Yes, Erythromycin Estolate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2218877. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 441371. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

¿Busca información accesible para el paciente?

Erythromycin Estolate en PillFYI

Estructura

Datos Rápidos

Fórmula: C52H97NO18S

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.